The Readout Loud 314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
Jul 18, 2024
JD Vance, Donald Trump's running mate, discusses healthcare policies if Trump wins. They cover shortages of insulin and focus on GLP-1 drugs. Also, the controversy over Cassava's Alzheimer's drug and leadership changes at Gilead.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
A Toast to Stock Success
02:09 • 5min
Resignations and Scrutiny at Cassava Sciences
07:00 • 2min
Challenges in Diabetes Drug Manufacturing and Supply
08:37 • 8min
Challenges and Changes at Gilead Sciences
16:49 • 4min
JD Vance's Influence on Healthcare Policies in the Trump Administration
20:22 • 13min